pharmaceutical

• SEC Targets UBS Banker in Case of Insider Trading

  By Janet Levaux, AdvisorOne  |  March 25, 2010

  Also, the U.S. Attorney's office in New York filed criminal charges against Igor Poteroba, a healthcare banker in the Swiss bank's New York office, and his friend, Aleksey Koval.

• Health Care: Potent Pipelines

  By Janet Levaux, AdvisorOne  |  March 1, 2010

  Damien Conover, CFA Karen Andersen, CFA Morningstar 312-696-6000 Pharmaceuticals: While the majority of pharmaceutical companies are losing patents on major blockbuster drugs over the next five years, strong pipelines...

• High Hopes and Altered Genes

  By Kenneth Silber, Research  |  October 1, 2009

  Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...

• The Right Remedies

  By Janet Levaux, AdvisorOne  |  September 1, 2009

  Research's Health Care Guide: Beckman Coulter Inc. (BEC) Roche Holding AG (RHHBY) Watson Pharmaceuticals Inc. (WPI) --- Karen Andersen,...

• To Your Health

  By Stan Luxenburg  |  March 1, 2009

  During 2008, health funds lost 23.3%, according to Morningstar. While shareholders may have seen little reason to cheer, the group did outdo the S&P 500...

• Biotech/Health Care

  By Janet Levaux, AdvisorOne  |  September 1, 2008

  Thanks to new drugs, acquisitions and other factors, biotech and health-care firms alike are forging beneficial growth and development strategies - which is good news...

• A brain workout

  By Staff Writer  |  May 1, 2008

  According to redOrbit.com, a new "brain fitness" software industry is emerging as aging baby boomers seek to keep not only their bodies, but their minds...

• Healthy Entrance

  By Janet Levaux, AdvisorOne  |  March 1, 2008

  Stocks in health care, including biotech and pharmaceuticals, are poised for higher levels in 2008 - thanks to present valuations, developing pipelines and acquisition horizons,...

• Opportunities in Hospital Infection Control

  By Staff Writer  |  December 4, 2007

  Medical device and pharmaceutical companies are seizing the opportunity to help hospitals with infection control. While interest in infection control isn't new, hospitals are under greater pressure to control HAIs, as bacteria become more resistant to existing therapies and payers tally the mounting costs of treatment for complications that might...

• Product Push

  By Staff Writer  |  December 1, 2007

  A select group of market segments and companies are poised to improve results in the coming months, analysts say. --- Analyst: Ronald A. Tadross, CFAFirm: Banc of...